期刊文献+

系统性红斑狼疮患者骨髓间充质干细胞衰老的研究进展 被引量:1

Senescence of bone marrow mesenchymal stem cells in patients with systemic lupus erythematosus
原文传递
导出
摘要 系统性红斑狼疮(SLE)是一种累及多器官、多系统的临床表现多样的慢性自身免疫性疾病。骨髓间充质干细胞(BMSC)是一类中胚层来源的非造血干细胞,是造血微环境的重要成分。多项研究表明,SLE是一种干细胞疾病,不仅造血干细胞存在异常,间充质细胞(MSC)也存在异常,具体表现为:生物学特征改变、细胞骨架及超微结构异常、端粒缩短、端粒酶及SA-β-Gal活性增强、分化能力减弱、免疫调节功能异常等衰老特征;其衰老机制可能与MSC内p53/p21cip1、p16INK4a/Rb、p27kip1/pTEN表达上调、ROS水平升高、内质网应激、表观遗传学改变等有关。 Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multi-organ and multisystemic involvement and various clinical manifestations. Bone marrow mesenchymal stem cells (BM-MSCs), a kind of non-hematopoietic stem cells originating from the mesoderm, are key components of hematopoietic microenvironment. Recent studies have indicated that SLE is a disorder of stem cells. Both hematopoietic and mesenchymal stem cells (MSCs) are abnormal in SLE, which mainly manifests as changes of biological characteristics, abnormal cytoskeleton and ultrastructure, shortened telomeres, increased telomerase and SA-β-Gal acitivity, decreased differentiative ability, aberrant immunoregulatory effect, and other features of senescence. The mechanism of MSC aging may be related to up-regulated expressions of aging-related genes p53/p21cip1, p16INK4a/Rb and p27kip1/pTEN, elevated levels of reactive oxygen species (ROS), endoplasmic reticulum stress, epigenetic alterations, etc.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2016年第1期68-71,共4页 Chinese Journal of Dermatology
基金 广东省自然科学基金(2014A030313317)
关键词 红斑狼疮 系统性 间质干细胞 衰老 造血干细胞 端粒 后成说 遗传 Lupus erythematosus, systemic Mesenchymal stem cells Aging Hematopoietic stem cells Telomere Epigenesis, genetic
  • 相关文献

参考文献25

  • 1Shi D, Li X, Chen H, et al. High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus [J]. Pathol Biol (Paris), 2014, 62(6): 382-390. DOI: 10.1016/j.pathio.2014. 07.009.
  • 2Nauta A J, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells [J]. Blood, 2007, 110( 10): 3499-3506. DOI: 10.1182/ blood-2007-02-069716.
  • 3Sun LY, Zhang HY, Feng XB, et al. Abnormality of bone marrow- derived mesenchymal stem cells in patients with systemic lupus erythematosus [J]. Lupus, 2007, 16 (2): 121-128. DOI: 10.1177/ 0961203306075793.
  • 4Nie Y, Lau C, Lie A, et al. Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus [ J ]. Lupus, 2010, 19(7): 850-859. DOI: 10.1177/0961203309361482.
  • 5Li X, Liu L, Meng D, et al. Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem ceils in patients with systemic lupus erythematosus [J]. Stem Cells Dev, 2012, 21 (13): 2387-2394. DOI: 10.1089/scd.2011.0447.
  • 6Tang XL, Griffith JF, Qin L, et al. SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength [J]. Lupus, 2013, 22 (11): 1162-1168. DOI: 10.1177/ 0961203313498802.
  • 7孟德芳,刘蕾,汤郁,施冬艳,张继云,王丹丹,孙凌云.系统性红斑狼疮女性患者骨髓间充质干细胞衰老与细胞内活性氧的相关性研究[J].中华风湿病学杂志,2011,15(4):229-233. 被引量:2
  • 8Buseman CM, Wright WE, Shay JW. Is telomerase a viable target in cancer? [J]. Mutat Res, 2012, 730 (1-2): 90-97. DOI: 10.1016/j. mrfmmm.2011.07.006.
  • 9Armstrong L, Lako M, Lincoln J, et al. mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells[J]. Mech Dev, 2000, 97(1-2): 109-116. DOI: 10.1016/S0925-4773 (00)00423-8.
  • 10Madonna R, Taylor DA, Geng YJ, et al. Transplantation of mesen- chymal ceils rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia[J]. Circ Res, 2013, 113(7): 902-914. DOI: 10.1161/CIRCRESAHA. 113.301690.

二级参考文献3

共引文献1

同被引文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部